eFFECTOR Therapeutics Inc... (EFTR)
0.00
null (null%)
At close: Jan 14, 2025, 8:00 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 14.88M | 8.71M | 49.70M | 15.22M | 3.43M |
| Short-Term Investments | 3.50M | 17.60M | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 513.00K | 711.00K | 903.00K | -126.00K | -823.00K |
| Receivables | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | -27.00K | -100.00K | n/a | n/a |
| Other Current Assets | 1.47M | 1.70M | 6.39M | 2.72M | 845.00K |
| Total Current Assets | 19.84M | 28.01M | 52.90M | 16.58M | 4.27M |
| Property-Plant & Equipment | 193.00K | 352.00K | 257.00K | 126.00K | 823.00K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 706.00K | 1.06M | 1.16M | 126.00K | 823.00K |
| Total Assets | 20.54M | 29.08M | 54.06M | 16.70M | 5.09M |
| Account Payables | 2.33M | 1.49M | 516.00K | 347.00K | 598.00K |
| Deferred Revenue | n/a | n/a | n/a | 1.98M | n/a |
| Short-Term Debt | 20.55M | 20.22M | 88.00K | 6.01M | 15.24M |
| Other Current Liabilities | 2.92M | 2.90M | 3.02M | 2.07M | 3.09M |
| Total Current Liabilities | 25.80M | 25.07M | 3.98M | 8.78M | 18.93M |
| Long-Term Debt | n/a | 120.00K | 19.99M | 6.95M | n/a |
| Other Long-Term Liabilities | 543.00K | -14.00K | 12.81M | 133.22M | n/a |
| Total Long-Term Liabilities | 543.00K | 106.00K | 32.79M | 140.17M | n/a |
| Total Liabilities | 26.34M | 25.18M | 36.77M | 148.95M | 18.93M |
| Total Debt | 20.55M | 20.28M | 20.03M | 12.96M | 15.24M |
| Common Stock | n/a | 4.00K | 4.00K | 1K | 1K |
| Retained Earnings | -179.38M | -143.57M | -120.90M | -136.70M | -150.91M |
| Comprehensive Income | n/a | -18.00K | -54.06M | -133.22M | -999 |
| Shareholders Equity | -5.79M | 3.90M | 17.28M | -132.25M | -13.84M |
| Total Investments | 3.50M | 17.60M | n/a | n/a | n/a |